Atlas Trials

A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma

Clinical trial NCT01800071 · COMPLETED

Trial details

NCT number
NCT01800071
Sponsor
Cancer Research UK
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Nasopharyngeal CancerEpstein Barr Virus Infections
Start date
2013-03-01
Primary completion
2017-03-10
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.